Cytogen (Korea) Market Value

217330 Stock  KRW 4,265  70.00  1.61%   
Cytogen's market value is the price at which a share of Cytogen trades on a public exchange. It measures the collective expectations of Cytogen investors about its performance. Cytogen is trading at 4265.00 as of the 17th of March 2025, a 1.61 percent decrease since the beginning of the trading day. The stock's open price was 4335.0.
With this module, you can estimate the performance of a buy and hold strategy of Cytogen and determine expected loss or profit from investing in Cytogen over a given investment horizon. Check out Cytogen Correlation, Cytogen Volatility and Cytogen Alpha and Beta module to complement your research on Cytogen.
Symbol

Please note, there is a significant difference between Cytogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Cytogen 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cytogen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cytogen.
0.00
12/17/2024
No Change 0.00  0.0 
In 3 months and 1 day
03/17/2025
0.00
If you would invest  0.00  in Cytogen on December 17, 2024 and sell it all today you would earn a total of 0.00 from holding Cytogen or generate 0.0% return on investment in Cytogen over 90 days. Cytogen is related to or competes with Union Materials, PI Advanced, Moonbae Steel, Hyosung Advanced, Solus Advanced, INNOX Advanced, and RF Materials. Cytogen, Inc., a biotechnology company, develops and sells CTC enrichment and downstream systems to treat cancer in Sout... More

Cytogen Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cytogen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cytogen upside and downside potential and time the market with a certain degree of confidence.

Cytogen Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Cytogen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cytogen's standard deviation. In reality, there are many statistical measures that can use Cytogen historical prices to predict the future Cytogen's volatility.
Hype
Prediction
LowEstimatedHigh
4,2624,2654,268
Details
Intrinsic
Valuation
LowRealHigh
4,0064,0094,692
Details
Naive
Forecast
LowNextHigh
4,4084,4104,413
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
4,1354,3584,581
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cytogen. Your research has to be compared to or analyzed against Cytogen's peers to derive any actionable benefits. When done correctly, Cytogen's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Cytogen.

Cytogen Backtested Returns

Cytogen secures Sharpe Ratio (or Efficiency) of -0.2, which signifies that the company had a -0.2 % return per unit of risk over the last 3 months. Cytogen exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cytogen's Standard Deviation of 5.5, risk adjusted performance of (0.01), and Mean Deviation of 3.18 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.69, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cytogen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cytogen is expected to be smaller as well. At this point, Cytogen has a negative expected return of -0.54%. Please make sure to confirm Cytogen's maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to decide if Cytogen performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.23  

Weak predictability

Cytogen has weak predictability. Overlapping area represents the amount of predictability between Cytogen time series from 17th of December 2024 to 31st of January 2025 and 31st of January 2025 to 17th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cytogen price movement. The serial correlation of 0.23 indicates that over 23.0% of current Cytogen price fluctuation can be explain by its past prices.
Correlation Coefficient0.23
Spearman Rank Test0.21
Residual Average0.0
Price Variance11.6 K

Cytogen lagged returns against current returns

Autocorrelation, which is Cytogen stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cytogen's stock expected returns. We can calculate the autocorrelation of Cytogen returns to help us make a trade decision. For example, suppose you find that Cytogen has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Cytogen regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cytogen stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cytogen stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cytogen stock over time.
   Current vs Lagged Prices   
       Timeline  

Cytogen Lagged Returns

When evaluating Cytogen's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cytogen stock have on its future price. Cytogen autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cytogen autocorrelation shows the relationship between Cytogen stock current value and its past values and can show if there is a momentum factor associated with investing in Cytogen.
   Regressed Prices   
       Timeline  

Pair Trading with Cytogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytogen will appreciate offsetting losses from the drop in the long position's value.

Moving against Cytogen Stock

  0.63021240 COWAY CoPairCorr
  0.55098460 Koh Young TechnologyPairCorr
  0.44225220 Genolution Earnings Call This WeekPairCorr
  0.44029780 Samsung CardPairCorr
  0.42293780 AptaBio TherapeuticsPairCorr
The ability to find closely correlated positions to Cytogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytogen to buy it.
The correlation of Cytogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytogen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Cytogen Stock

Cytogen financial ratios help investors to determine whether Cytogen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cytogen with respect to the benefits of owning Cytogen security.